Hamid Khoja, Ph.D., Chief Scientific Officer

Oct. 10 | 10:45am | Rentschler ATMP Ballroom 

Houston, TX


FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments for chronic diseases using fibroblast cells. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.


By using this website you agree to accept our Privacy Policy and Terms & Conditions